ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
159 hedge funds and large institutions have $1.73B invested in Alder Biopharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
75% less call options, than puts
Call options by funds: $2.71M | Put options by funds: $10.9M
Holders
159
Holding in Top 10
5
Calls
$2.71M
Puts
$10.9M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$23M | |
| 3 | +$13.2M | |
| 4 |
SIG
Senator Investment Group
New York
|
+$9.79M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.52M |
Top Sellers
| 1 | -$62M | |
| 2 | -$18.8M | |
| 3 | -$17.8M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$13.7M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$12.3M |